Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis
- PMID: 38735022
- PMCID: PMC11089016
- DOI: 10.1186/s13244-024-01706-8
Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis
Erratum for
-
The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis.Insights Imaging. 2024 Feb 27;15(1):64. doi: 10.1186/s13244-024-01629-4. Insights Imaging. 2024. PMID: 38411746 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
